Interaction of S17 antibody with the functional binding region of the hepatitis B virus pre-S2 epitope

Chang Yu Chang, Fu Ling Chang, Chen Wei Chiang, Yan Ni Lo, Tsai Yu Lin, Wang Chuan Chen, Keng Chang Tsai, Yu Ching Lee

Research output: Contribution to journalArticle

Abstract

To understand the mechanism for inhibition of hepatitis B virus (HBV) infection is important. In this study, single-chain variable fragment (scFv) antibodies were generated and directed to the pre-S2 epitope of HBV surface antigen (HBsAg). These human scFvs were isolated from a person with history of HBV infection by phage display technology. An evaluation of panning efficiency revealed that the eluted phage titer was increased, indicating that specific clones were enriched after panning. Selected scFvs were characterized with the recombinant HBsAg through Western blotting and enzyme-linked immunosorbent assay to confirm the binding ability. Flow cytometry analysis and immunocytochemical staining revealed that one scFv, S17, could recognize endogenous HBsAg expressed on the HepG2215 cell membrane. Moreover, the binding affinity of scFv S17 to the pre-S2 epitope was determined to be 4.2 10-8 M. Two ion interactions were observed as the major driving forces for scFv S17 interacting with pre-S2 by performing a rational molecular docking analysis. This study provides insights into the structural basis to understand the interactions between an antibody and the pre- S2 epitope. The functional scFv format can potentially be used in future immunotherapeutic applications.

Original languageEnglish
Pages (from-to)492-499
Number of pages8
JournalViral Immunology
Volume31
Issue number7
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Hepatitis B virus
Epitopes
Single-Chain Antibodies
Virus Diseases
Surface Antigens
Bacteriophages
Antibodies
Molecular Docking Simulation
Hepatitis B Surface Antigens
Flow Cytometry
Clone Cells
Western Blotting
Enzyme-Linked Immunosorbent Assay
Cell Membrane
Ions
Staining and Labeling
Technology

Keywords

  • Hepatitis B virus
  • Molecular docking
  • Phage display technology
  • Pre-S2 epitope
  • Single-chain variable fragment

ASJC Scopus subject areas

  • Immunology
  • Molecular Medicine
  • Virology

Cite this

Interaction of S17 antibody with the functional binding region of the hepatitis B virus pre-S2 epitope. / Chang, Chang Yu; Chang, Fu Ling; Chiang, Chen Wei; Lo, Yan Ni; Lin, Tsai Yu; Chen, Wang Chuan; Tsai, Keng Chang; Lee, Yu Ching.

In: Viral Immunology, Vol. 31, No. 7, 01.09.2018, p. 492-499.

Research output: Contribution to journalArticle

Chang, CY, Chang, FL, Chiang, CW, Lo, YN, Lin, TY, Chen, WC, Tsai, KC & Lee, YC 2018, 'Interaction of S17 antibody with the functional binding region of the hepatitis B virus pre-S2 epitope', Viral Immunology, vol. 31, no. 7, pp. 492-499. https://doi.org/10.1089/vim.2017.0200
Chang, Chang Yu ; Chang, Fu Ling ; Chiang, Chen Wei ; Lo, Yan Ni ; Lin, Tsai Yu ; Chen, Wang Chuan ; Tsai, Keng Chang ; Lee, Yu Ching. / Interaction of S17 antibody with the functional binding region of the hepatitis B virus pre-S2 epitope. In: Viral Immunology. 2018 ; Vol. 31, No. 7. pp. 492-499.
@article{4bc8b0b1abf846b69683f026146bc56d,
title = "Interaction of S17 antibody with the functional binding region of the hepatitis B virus pre-S2 epitope",
abstract = "To understand the mechanism for inhibition of hepatitis B virus (HBV) infection is important. In this study, single-chain variable fragment (scFv) antibodies were generated and directed to the pre-S2 epitope of HBV surface antigen (HBsAg). These human scFvs were isolated from a person with history of HBV infection by phage display technology. An evaluation of panning efficiency revealed that the eluted phage titer was increased, indicating that specific clones were enriched after panning. Selected scFvs were characterized with the recombinant HBsAg through Western blotting and enzyme-linked immunosorbent assay to confirm the binding ability. Flow cytometry analysis and immunocytochemical staining revealed that one scFv, S17, could recognize endogenous HBsAg expressed on the HepG2215 cell membrane. Moreover, the binding affinity of scFv S17 to the pre-S2 epitope was determined to be 4.2 10-8 M. Two ion interactions were observed as the major driving forces for scFv S17 interacting with pre-S2 by performing a rational molecular docking analysis. This study provides insights into the structural basis to understand the interactions between an antibody and the pre- S2 epitope. The functional scFv format can potentially be used in future immunotherapeutic applications.",
keywords = "Hepatitis B virus, Molecular docking, Phage display technology, Pre-S2 epitope, Single-chain variable fragment",
author = "Chang, {Chang Yu} and Chang, {Fu Ling} and Chiang, {Chen Wei} and Lo, {Yan Ni} and Lin, {Tsai Yu} and Chen, {Wang Chuan} and Tsai, {Keng Chang} and Lee, {Yu Ching}",
year = "2018",
month = "9",
day = "1",
doi = "10.1089/vim.2017.0200",
language = "English",
volume = "31",
pages = "492--499",
journal = "Viral Immunology",
issn = "0882-8245",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Interaction of S17 antibody with the functional binding region of the hepatitis B virus pre-S2 epitope

AU - Chang, Chang Yu

AU - Chang, Fu Ling

AU - Chiang, Chen Wei

AU - Lo, Yan Ni

AU - Lin, Tsai Yu

AU - Chen, Wang Chuan

AU - Tsai, Keng Chang

AU - Lee, Yu Ching

PY - 2018/9/1

Y1 - 2018/9/1

N2 - To understand the mechanism for inhibition of hepatitis B virus (HBV) infection is important. In this study, single-chain variable fragment (scFv) antibodies were generated and directed to the pre-S2 epitope of HBV surface antigen (HBsAg). These human scFvs were isolated from a person with history of HBV infection by phage display technology. An evaluation of panning efficiency revealed that the eluted phage titer was increased, indicating that specific clones were enriched after panning. Selected scFvs were characterized with the recombinant HBsAg through Western blotting and enzyme-linked immunosorbent assay to confirm the binding ability. Flow cytometry analysis and immunocytochemical staining revealed that one scFv, S17, could recognize endogenous HBsAg expressed on the HepG2215 cell membrane. Moreover, the binding affinity of scFv S17 to the pre-S2 epitope was determined to be 4.2 10-8 M. Two ion interactions were observed as the major driving forces for scFv S17 interacting with pre-S2 by performing a rational molecular docking analysis. This study provides insights into the structural basis to understand the interactions between an antibody and the pre- S2 epitope. The functional scFv format can potentially be used in future immunotherapeutic applications.

AB - To understand the mechanism for inhibition of hepatitis B virus (HBV) infection is important. In this study, single-chain variable fragment (scFv) antibodies were generated and directed to the pre-S2 epitope of HBV surface antigen (HBsAg). These human scFvs were isolated from a person with history of HBV infection by phage display technology. An evaluation of panning efficiency revealed that the eluted phage titer was increased, indicating that specific clones were enriched after panning. Selected scFvs were characterized with the recombinant HBsAg through Western blotting and enzyme-linked immunosorbent assay to confirm the binding ability. Flow cytometry analysis and immunocytochemical staining revealed that one scFv, S17, could recognize endogenous HBsAg expressed on the HepG2215 cell membrane. Moreover, the binding affinity of scFv S17 to the pre-S2 epitope was determined to be 4.2 10-8 M. Two ion interactions were observed as the major driving forces for scFv S17 interacting with pre-S2 by performing a rational molecular docking analysis. This study provides insights into the structural basis to understand the interactions between an antibody and the pre- S2 epitope. The functional scFv format can potentially be used in future immunotherapeutic applications.

KW - Hepatitis B virus

KW - Molecular docking

KW - Phage display technology

KW - Pre-S2 epitope

KW - Single-chain variable fragment

UR - http://www.scopus.com/inward/record.url?scp=85053125271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053125271&partnerID=8YFLogxK

U2 - 10.1089/vim.2017.0200

DO - 10.1089/vim.2017.0200

M3 - Article

AN - SCOPUS:85053125271

VL - 31

SP - 492

EP - 499

JO - Viral Immunology

JF - Viral Immunology

SN - 0882-8245

IS - 7

ER -